Long‐term treatment of Parkinson's disease with L‐Dopa and Dopa‐decarboxylase inhibitor: Therapeutic results and side effects

L. Battistin,G. Meneghetti,Simone Rigotti,A. Saia
DOI: https://doi.org/10.1111/j.1600-0404.1978.tb02836.x
1978-02-01
Acta Neurologica Scandinavica
Abstract:The authors present a review of their clinical experience in the treatment of 127 Parkinsonian patients with L‐Dopa alone and in association with a Dopa‐decarboxylase inhibitor; the follow‐up lasted more than 7 years.
What problem does this paper attempt to address?